CDK9 and urinary bladder carcinoma: In this study, we primarily identified a novel lncRNA termed GAS6‐AS2, and our research proved that GAS6‐AS2 contributed to proliferation and metastasis of bladder cancer cells via the GAS6‐AS2/miR‐298/CDK9 axis.